[ad_1]
Currently, the public health network has only the 20 mg version of the remedy. According to the Ministry of Health, this novelty will allow the patient to reduce from seven to three doses injected each week, thus ensuring a better quality of life. . According to the federal government, approximately 85% of patients with the disease are initially diagnosed as recurrent referrals. "Recurrent shippers" are characterized by epidemics of neurological dysfunction with complete or partial recovery that resolve spontaneously
The other levels are "secondarily progressive" and "mainly progressive".
Numbers
Worldwide, it is estimated that 33 out of every 100,000 people suffer from multiple sclerosis. In Brazil, the Ministry of Health calculated that 35,000 people had the disease and that 15,000 were treated at SUS.
Affected
This condition usually affects adults aged 18 to 55 years. In addition, it is two to three times more common among women. Major symptoms include fatigue, tingling and burning in the limbs, blurred vision, double vision, vision loss, dizziness, stiffness. Muscular and cognitive problems.
* Provided by Agência Brazil
[ad_2]
Source link
